Page last updated: 2024-08-16

temozolomide and at 13387

temozolomide has been researched along with at 13387 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Abas, FS; Beattie, CE; Canella, A; Gumin, J; Gurcan, MN; Kaur, B; Kesanakurti, D; Lang, FF; Liu, J; Nagarajan, P; Puduvalli, VK; Sampath, D; Sulman, EP; Welker, AM; Xu, J; Yoo, JY1
Beattie, CE; Canella, A; Easley, M; Elder, JB; Jacob, NK; Lai, TH; Lang, F; Lonser, R; Pietrzak, M; Puduvalli, VK; Sampath, D; Sharma, P; Timmers, CM; Welker, AM; Wu, PJ; Xu, J1

Other Studies

2 other study(ies) available for temozolomide and at 13387

ArticleYear
Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2017, Oct-15, Volume: 23, Issue:20

    Topics: Animals; Antineoplastic Agents; Benzamides; Blood-Brain Barrier; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dacarbazine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression; Glioma; HSP90 Heat-Shock Proteins; Humans; Isoindoles; Mice; Neoplastic Stem Cells; Protein Transport; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases; Signal Transduction; Survival Rate; Temozolomide; Xenograft Model Antitumor Assays; Zebrafish

2017
Disruption of DNA Repair and Survival Pathways through Heat Shock Protein Inhibition by Onalespib to Sensitize Malignant Gliomas to Chemoradiation Therapy.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2022, 05-02, Volume: 28, Issue:9

    Topics: Animals; Antineoplastic Agents; Benzamides; Brain Neoplasms; Cell Line, Tumor; DNA Repair; Glioblastoma; Glioma; Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Isoindoles; Mice; Temozolomide; Xenograft Model Antitumor Assays; Zebrafish

2022